Jay Pepose - Jun 7, 2021 Form 3 Insider Report for Ocuphire Pharma, Inc. (OCUP)

Role
Director
Signature
/s/ Emily J. Johns, by Power of Attorney
Stock symbol
OCUP
Transactions as of
Jun 7, 2021
Transactions value $
$0
Form type
3
Date filed
6/9/2021, 05:19 PM
Next filing
Sep 15, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding OCUP Common Stock 2.11K Jun 7, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding OCUP Stock Option (right to buy) Jun 7, 2021 Common Stock 4.23K $1.15 Direct F1
holding OCUP Stock Option (right to buy) Jun 7, 2021 Common Stock 10.6K $1.65 Direct F1
holding OCUP Stock Option (right to buy) Jun 7, 2021 Common Stock 30K $4.05 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options are fully vested.
F2 625 shares vesting on the last day of each month from November 2020 to October 2024 with the balance vesting in the last month, subject to the Reporting Person's continuing service through the vesting date.

Remarks:

Exhibit 24, Power of Attorney, is attached.